NCT Number,Study Title,Study URL,Acronym,Study Status,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Age,Phases,Study Type,Study Design,Other IDs,Study Documents
NCT03414918,Macrolides for KCNJ5 - Mutated Aldosterone-Producing Adenoma (MAPA),https://beta.clinicaltrials.gov/study/NCT03414918,MAPA,UNKNOWN,NO,Hyperaldosteronism,DRUG: Clarithromycin,"Study 1: Change in Relative Aldosterone Secretion Index (RASI)., Within-patient change from baseline of the RASI in adrenal vein blood draining the gland with and without the APA., Baseline and after 45min clarithromycin infusion.|Study 2: Change in plasma aldosterone concentration (PAC)., Within-patient change from baseline of PAC in peripheral venous blood in patients undergoing screening for PA., Baseline and after 60 and 120 minutes roxitromycin administration",,,University Hospital Padova,DMG Paris Descartes,"ADULT, OLDER_ADULT",NA,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC,4283/AO/17,
